AdvanCell
CompanyUnited States
AdvanCell develops one asset. Mostly other; based in the United States.
- 1
- Asset
- Furthest stage
- Not known
- Raised
- $330M + A$290M
- 0
- Trials
- 1
- Signal
Pipeline
1PSMA-targeted radiopharmaceutical delivering lead-212 alpha radiation to cancer cells.
Stage not known, Other
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Funding rounds and grants4
- People11
- Signals2